Missouri Trasylol Lawsuit Filed In St. Louis
TRASYLOL ATTORNEY KIDNEY DAMAGE MISSOURI LAWSUIT DRUG RECALL
A lawsuit has been filed against Bayer AG (maker of Trasylol) over man’s death after open-heart surgery in St. Louis.
A lawsuit has been filed in a St. Louis federal court against Bayer AG, the maker of the anti-bleeding drug Trasylol, on behalf of a man's widow. Her husband died of kidney failure after open-heart surgery.
In December 2005, Samuel Nakis, 81, underwent open-heart surgery at St. Luke’s Hospital. During the surgery he was given Trasylol (generic: aprotinin), a clotting drug used to prevent bleeding. After the surgery, Nakis experienced kidney failure and underwent dialysis and died a short time later.
The FDA approved Trasylol in 1993. In January 2006, the medical journal Transfusion published an article suggesting a link between Trasylol and renal toxicity. Later that same month, the New England Journal of Medicine published an article, by Dr. Dennis Mangano of the nonprofit Ischemia Research and Education Foundation, linking Trasylol to a much higher risk of stroke, heart attack and kidney failure.
Fall 2006: an FDA advisory board met to decide whether the warning on Trasylol needed to be changed and at this meeting Bayer failed to disclose the findings of a Trasylol study it had funded and found grave risks which they failed to report. That study, conducted by Dr. Alexander Walker, a professor at the Harvard School of Public Health, reviewed the hospital records of over 67,000 patients and found that Trasylol had a risk of death 64 percent higher than that of patients who received a comparison drug. Shockingly, it wasn’t until November 2007 that the drug was finally pulled from the market.
The New England Journal of Medicine released the study conducted by Walker and a second study conducted by Duke University Medical Center researchers. Both of which confirmed patients given Trasylol during heart surgery were more likely to die than patients given a comparable drug.
The lawsuit alleges Bayer failed to warn prescribers and consumers of the dangers associated with the drug, defectively designed the drug, fraudulently concealed the dangers of the drug, breached the implied and express warranties and violated the Missouri Merchandising Practices Act and seeks big money.
Cardin & Payne Attorneys are Trasylol Lawyers willing to talk with you about a possible case.
